Ticker brief
BHVN BIOHAVEN LTD
Consumer, Non-cyclical · Biotechnology
last close
$13.88
1 day
-5.5%
14 days
+14.9%
mkt cap
·
signals 14d
6
authors 14d
6
crowd 14d
-0.4σ
Sentiment — last 14 days
daily mean sentiment, 2026-10-08 → 2026-10-09 · now +0.40 (−1 bearish … +1 bullish)
Who spoke6
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @PersimmonTI | A | +0.79 | 1 | -0.20 |
| @BioStocks | C | -1.77 | 1 | +0.45 |
| @tenet_research | C | -1.23 | 1 | +0.00 |
| @TENETTRADEGROUP | C | -0.65 | 1 | +0.00 |
| @OpenOutcrier | C | · | 1 | +0.35 |
| @Quantumup1 | C | +0.10 | 1 | +0.40 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-09 | @Quantumup1 | +0.40 | Canaccord reiterated Buy and a $21 target after a licensing deal. | +14.9% | tweet ↗ |
| 2026-10-08 | @OpenOutcrier | +0.35 | Biohaven licensed its IgG degrader portfolio to Ono for $100M. | +16.3% | tweet ↗ |
| 2026-10-08 | @TENETTRADEGROUP | +0.00 | Lists premarket movers without giving direction or catalysts in the text. | +16.3% | tweet ↗ |
| 2026-10-08 | @tenet_research | +0.00 | Lists pre-market movers, but the attached image is required for their directions and magnitudes. | +16.3% | tweet ↗ |
| 2026-10-08 | @BioStocks | +0.45 | Biohaven licensed IgG degraders to Ono Pharma in Asia for an $80 million upfront payment. | +16.3% | tweet ↗ |
| 2026-10-08 | @PersimmonTI | -0.20 | Cryptic criticism of a named person is presented in connection with BHVN. | +16.3% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.